Meeting to be held in New York on June 3 hosted by BTIG.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MREO:
- Buy Rating for Mereo Biopharma Group Plc: Strategic Positioning and Promising Developments in Osteogenesis Imperfecta Treatment
- Positive Outlook for Mereo Biopharma Group Plc: Buy Rating Supported by Promising Lead Programs and Strong Financial Position
- Mereo Biopharma Passes Key Resolutions at AGM
- Optimistic Buy Rating for Mereo Biopharma: Promising Outlook for Setrusumab in Osteogenesis Imperfecta
- Mereo BioPharma Reports Q1 2025 Financial Results